title: Sphingomonas paucimobilis bacteremia related to intravenous human immunoglobulin injections.
authors.forename: J-P
authors.initials: JP
authors.lastname: Lanoix
authors.forename: F
authors.initials: F
authors.lastname: Hamdad
authors.forename: A
authors.initials: A
authors.lastname: Borel
authors.forename: D
authors.initials: D
authors.lastname: Thomas
authors.forename: V
authors.initials: V
authors.lastname: Salle
authors.forename: A
authors.initials: A
authors.lastname: Smail
authors.forename: Y
authors.initials: Y
authors.lastname: El Samad
authors.forename: J-L
authors.initials: JL
authors.lastname: Schmit
mesh_terms: D000361:Agammaglobulinemia / Q000628:therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D055499:Catheter-Related Infections / Q000188:drug therapy / Q000382:microbiology*; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D003428:Cross Infection / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D004340:Drug Contamination; D004866:Equipment Contamination; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D016867:Immunocompromised Host; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008224:Lymphoma, Follicular / Q000150:complications / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy; D011183:Postoperative Complications / Q000628:therapy; D020578:Sphingomonas / Q000302:isolation & purification*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous